Biogened S.A. (WSE:BGD)
Poland · Delayed Price · Currency is PLN 19.00
0.00 (0.00%)
Last updated: Nov 3, 2026, 1:05 PM CET
Biogened Market Cap
Biogened has a market cap or net worth of 46.67 million as of November 3, 2026. It is the 40,354th most valuable company in the world and the 355th biggest in Poland. Its market cap has decreased by 9.52% in one year.
Market Cap
46.67M
Enterprise Value
65.42M
Revenue
110.11M
Global Rank
Country Rank
#355 Poland
PE Ratio
9.10
ChartMarket Cap Chart
Since August 31, 2011, Biogened's market cap has increased from 45.77M to 46.67M, an increase of 1.97%. That is a compound annual growth rate of 0.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 46.67M | -12.04% |
| Dec 30, 2025 | 53.06M | -6.09% |
| Dec 30, 2024 | 56.50M | 27.78% |
| Dec 29, 2023 | 44.21M | 41.73% |
| Dec 29, 2022 | 31.20M | 47.67% |
| Dec 30, 2021 | 21.12M | 1.18% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 4.98B |
| NEUCA | 3.10B |
| Synektik Spólka Akcyjna | 2.75B |
| Voxel | 1.59B |
| Urteste | 64.25M |
| Read-Gene | 55.41M |
| Genomed Spólka Akcyjna | 49.95M |
| Genomtec | 43.43M |